Ace the CRNI Challenge 2025 – Infuse Your Career with Success!

Neupogen, a brand name for filgrastim, is specifically designed to stimulate the bone marrow's production of neutrophils, which are a type of white blood cell crucial for fighting off infections, particularly in patients undergoing chemotherapy or those with conditions that severely impact their immune response. By helping to increase neutrophil counts, Neupogen plays a vital role in preventing infection in these vulnerable patients.

The other options do not align with the pharmacological action of Neupogen. For instance, treating severe dehydration typically involves fluid and electrolyte replenishment rather than bone marrow stimulation. Lowering cholesterol levels relates to medications like statins, which are aimed at managing lipid profiles in the body, and reducing inflammation is better associated with corticosteroids or non-steroidal anti-inflammatory drugs (NSAIDs). Therefore, the specific function of Neupogen as a bone marrow stimulant is what distinguishes it in the context of this question.